A would-be Chinese immigrant businesswoman is suing a troubled BC Cancer Agency spinoff company after…
Celgene Corp. to pay $280M to settle cancer drug fraud suit
Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another therapy for unapproved cancer treatments,...